Skip to main content

Regulatory activities to address the needs of older patients

The journal of nutrition, health & aging volume 19, pages 232–233 (2015)Cite this article

Abstract

At the Drug Information Association (DIA) 49th annual meeting, for the first time regulators (Dr Francesca Cerreta, Dr Robert Temple and Dr Yasuko Asahina) from the three International Conference on Harmonization (ICH) co-sponsor regions came together in a forum to discuss their perspective on how the aging population impacts on drug development and on the design of clinical trials. In 2010, the ICH E7 Guideline (Studies in support of Special Populations: Geriatrics) was revised with the addition of a Questions and Answers document to take into account the rapidly changing world demographics. Regulators from the three ICH regions (Europe, USA and Japan) discuss here how they foresee the application of this guideline, and the impact that this might have on new drug development and clinical trial design. This article aims to summarize the discussions at the session for the benefit of a wider audience.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. International Conference on Harmonization (1993) Studies in support of special populations: Geriatrics E7. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E7/Step4/E7_Guideline.pdf. Accessed 5 May 2014

    Google Scholar 

  2. European Medicines Agency (2011) EMA geriatric medicines strategy. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E7/Step4/E7_Guideline.pdf. Accessed 5 May 2014.

    Google Scholar 

  3. International Conference on Harmonization (2010) E7 Studies in support of special populations: Geriatrics questions & answers. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E7/Q_As/E7_Q_As_step4.pdf. Accessed 5 May 2014.

    Google Scholar 

  4. Asahina Y, Sugano H, Sugiyama E, Uyama Y. Representation of older patients in clinical trials for drug approval in Japan. J Nutr Health Aging 2014;18:520–23.

    Article  CAS  PubMed  Google Scholar 

  5. Good Review Practice: Clinical Review of Investigational New Drug Applications.http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/UCM377108.pdf. Accessed 26 May 2014.

  6. U.S. Food and Drug Administration (2011) White Paper: U.S. Food and Drug Administration (FDA) inventory of clinical trials protocols and clinical study data. http://www.fda.gov/downloads/drugs/developmentapprovalprocess/conductingcl inicaltrials/ucm309552.pdf. Accessed 5 May 2014.

    Google Scholar 

  7. European Medicines Agency (2013) Proposal for the development of a points to consider for baseline characterisation of frailty status. http://www.ema.europa.eu/docs/en_GB/document_library/Other/2013/06/WC500144373.pdf. Accessed 5 May 2014.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Human Medicines Research & Development Support Division, Scientific Advice, European Medicines Agency, London, UK

    Francesca Cerreta & C. Connaire

  2. Center for Drug Evaluation and Research, US Food and Drug Administration, London, UK

    R. Temple

  3. Office of New Drug II, Pharmaceuticals and Medical Devices Agency, London, UK

    Y. Asahina

  4. Human Medicines Research & Development Support Division, Scientific Advice, London, UK

    Francesca Cerreta

Authors
  1. Francesca Cerreta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Temple
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y. Asahina
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Connaire
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesca Cerreta.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cerreta, F., Temple, R., Asahina, Y. et al. Regulatory activities to address the needs of older patients. J Nutr Health Aging 19, 232–233 (2015). https://doi.org/10.1007/s12603-014-0494-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12603-014-0494-4

Key words

  • Older population
  • clinical development
  • regulators
  • pharmacokinetics
  • ICH E7